These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10681343)

  • 1. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Jalal S; Ciofu O; Hoiby N; Gotoh N; Wretlind B
    Antimicrob Agents Chemother; 2000 Mar; 44(3):710-2. PubMed ID: 10681343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
    Jalal S; Wretlind B
    Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa.
    Higgins PG; Fluit AC; Milatovic D; Verhoef J; Schmitz FJ
    Int J Antimicrob Agents; 2003 May; 21(5):409-13. PubMed ID: 12727072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A; Diver JM; Beckthold B; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
    J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X; Lind I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
    Mouneimné H; Robert J; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1999 Jan; 43(1):62-6. PubMed ID: 9869566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa.
    Yoshida T; Muratani T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1466-9. PubMed ID: 7979273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
    Salma R; Dabboussi F; Kassaa I; Khudary R; Hamze M
    J Infect Chemother; 2013 Feb; 19(1):77-81. PubMed ID: 22821356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.
    Takenouchi T; Sakagawa E; Sugawara M
    Antimicrob Agents Chemother; 1999 Feb; 43(2):406-9. PubMed ID: 9925546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R; Tankovic J; Soussy CJ
    Microb Drug Resist; 1998; 4(4):271-6. PubMed ID: 9988045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.
    Bast DJ; Low DE; Duncan CL; Kilburn L; Mandell LA; Davidson RJ; de Azavedo JC
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3049-54. PubMed ID: 11036021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.
    Yonezawa M; Takahata M; Matsubara N; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1970-2. PubMed ID: 8540700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.